Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
2.700
-0.070 (-2.53%)
At close: Aug 13, 2025, 4:00 PM
2.700
0.00 (0.00%)
Pre-market: Aug 14, 2025, 8:36 AM EDT
Annovis Bio Employees
As of December 31, 2024, Annovis Bio had 15 total employees, including 8 full-time and 7 part-time employees. The number of employees decreased by 1 or -6.25% compared to the previous year.
Employees
15
Change (1Y)
-1
Growth (1Y)
-6.25%
Revenue / Employee
n/a
Profits / Employee
-$2,017,343
Market Cap
52.61M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ANVS News
- 1 day ago - Annovis Provides Corporate Updates and Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 7 days ago - Annovis Completes Full Patent Transfer to Crystal Buntanetap - GlobeNewsWire
- 7 weeks ago - Annovis to Attend the AAIC 2025 with Four Poster Presentations - GlobeNewsWire
- 2 months ago - Annovis Announces NYSE Acceptance of Plan to Regain Listing Compliance - GlobeNewsWire
- 2 months ago - Annovis to Host Webinar and Live Q&A on June 24, 2025 - GlobeNewsWire
- 3 months ago - Annovis Provides Corporate Updates and Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 3 months ago - Annovis Bio Appoints Hui Liu as Director of Biostatistics - GlobeNewsWire
- 4 months ago - Annovis Bio, Inc. Receives Continued Listing Standard Notice From the NYSE - GlobeNewsWire